0.00Open0.10Pre Close0 Volume0 Open Interest2.50Strike Price0.00Turnover4647.79%IV-35.48%PremiumMay 17, 2024Expiry Date0.00Intrinsic Value100Multiplier-5DDays to Expiry0.10Time Value100Contract SizeAmericanOptions Type-0.1294Delta0.1619Gamma37.20Leverage Ratio-6.0194Theta0.0000Rho-4.81Eff Leverage0.0001Vega
NRX Pharmaceuticals Stock Discussion
Catching the attention of the pharmaceutical industry and investors alike, NRx Pharmaceuticals (Nasdaq: NRXP), a clinical-stage pharmaceutical company, has announced final clinical trial results showcasing a superior safety profile of NRX-101 over lurasidon...
NRX Pharmaceuticals (Nasdaq:Nrxp) Announces Final Clinical Trial Results: Superior Safety Combined With Similar Efficacy in the Trial of NRX-101 Compared to Lurasidone in Suicidal Bipolar Depression
No comment yet